Systematic Analysis of Human Telomeric Dysfunction Using Inducible Telosome/Shelterin CRISPR/Cas9 Knockout Cells

Total Page:16

File Type:pdf, Size:1020Kb

Systematic Analysis of Human Telomeric Dysfunction Using Inducible Telosome/Shelterin CRISPR/Cas9 Knockout Cells OPEN Citation: Cell Discovery (2017) 3, 17034; doi:10.1038/celldisc.2017.34 ARTICLE www.nature.com/celldisc Systematic analysis of human telomeric dysfunction using inducible telosome/shelterin CRISPR/Cas9 knockout cells Hyeung Kim1, Feng Li2, Quanyuan He1, Tingting Deng2, Jun Xu3, Feng Jin4, Cristian Coarfa4, Nagireddy Putluri4, Dan Liu1,3, Zhou Songyang1,2,* 1Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA; 2Key Laboratory of Gene Engineering of the Ministry of Education and State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China; 3Cell-Based Assay Screening Service Core, Baylor College of Med- icine, Houston, TX, USA; 4Department of Molecular and Cellular Biology and Advanced Technology Core, Baylor College of Medicine, Houston, TX, USA CRISPR/Cas9 technology enables efficient loss-of-function analysis of human genes using somatic cells. Studies of essential genes, however, require conditional knockout (KO) cells. Here, we describe the generation of inducible CRISPR KO human cell lines for the subunits of the telosome/shelterin complex, TRF1, TRF2, RAP1, TIN2, TPP1 and POT1, which directly interact with telomeres or can bind to telomeres through association with other subunits. Homozygous inactivation of several subunits is lethal in mice, and most loss-of-function studies of human telomere regulators have relied on RNA interference-mediated gene knockdown, which suffers its own limitations. Our inducible CRISPR approach has allowed us to more expediently obtain large numbers of KO cells in which essential telomere regulators have been inac- tivated for biochemical and molecular studies. Our systematic analysis revealed functional differences between human and mouse telomeric proteins in DNA damage responses, telomere length and metabolic control, providing new insights into how human telomeres are maintained. Keywords: CRISPR/Cas9; inducible knockout; metabolism; POT1 isoform; telomere; telosome/shelterin Cell Discovery (2017) 3, 17034; doi:10.1038/celldisc.2017.34; published online 26 September 2017 Introduction instance, TRF1 and TRF2 bind directly to the telomere duplex through their myb domains [9–13], whereas In the past 20 years, we have gained tremendous POT1 binds 3’ single-stranded (ss) telomeric overhangs insight into how the ends of mammalian chromosomes [14, 15]. RAP1 is recruited by TRF2, but apparently does or telomeres are maintained and regulated. Together not directly interact with any of the other subunits [16]. with the telomerase, which consists of the reverse tran- TIN2 can interact with both TRF1 and TRF2 [6, 17–21]. scriptase TERT and RNA template TR/TERC, a mul- It also binds TPP1 and helps bring to telomeres the titude of telomere-binding proteins participate in TPP1-POT1 heterodimer that is essential for regulating – telomere maintenance [1 5]. In particular, six core telo- telomerase access to telomeres [21–30]. The core telo- meric proteins, TRF1, TRF2, RAP1, TPP1, TIN2 and mere proteins often act as interaction hubs to recruit POT1, dynamically assemble on telomeres as a large factors of diverse pathways to telomeres and ensure complex called telosome or shelterin and are essential in crosstalk between telomere maintenance pathways and telomere length regulation and end protection in mam- other cellular processes [8, 19, 31, 32]. In fact, several key – mals [6 8]. Extensive research has revealed the interac- telomere regulators have been shown to regulate meta- tions and functions of telosome components. For bolism, providing direct evidence of the close ties between telomere regulation and metabolic control. For *Correspondence: Zhou Songyang example, the human telomerase reverse transcriptase has Tel: +713 798 5220; Fax: +713 796 9438 E-mail: [email protected] been found to localize to the mitochondria and reduce Received 15 March 2017; accepted 27 July 2017 intracellular oxidative stress [33–36]. Our lab has found Studying telosome subunits using inducible knockout cell lines 2 that TIN2 can also localize to the mitochondria and of their human orthologs, we first turned to RNAi KD regulate oxidative phosphorylation [37]. in human cells through stable expression of short Numerous studies have demonstrated that dysfunc- hairpin RNAs (Supplementary Figure S1A). Even with tional telomeres can lead to telomere length defects, effective KD (480%) of TRF2, for example, we could deprotected telomeres, genomic instability and diseases only observe minor DNA damage responses (DDRs) [1, 4, 32, 38]. Much of our knowledge regarding the at telomeres (data not shown), rarely more severe molecular and functional significance of mammalian telo- phenotypes such as chromosome end-to-end fusions meric proteins comes from studies using mouse knockout found in Trf2 KO MEF cells [50], suggesting that (KO) mouse embryonic fibroblast (MEF) cells, as genes residual TRF2 proteins in the KD cells may have been are more readily targeted in mouse embryonic stem cells. sufficient to prevent severe and sustained telomere However, notable differences exist in telomere regulation DNA damages. We next attempted straight KO of between mouse and human. For instance, human telo- these genes by CRISPR/Cas9, but failed to isolate any meres are considerably shorter than those of laboratory clones of TRF2, TIN2 or POT1 KO cells. Given such mice and human has one POT1 gene, whereas mouse has findings, we decided that human cells conditionally two (Pot1a and Pot1b). Such disparities underscore the knocked out for telosome subunits would be more need for loss-of-function human cellular models. Majority desirable. of the loss-of-function studies in human cells have relied on Traditionally, conditional KO alleles are generated RNA interference (RNAi)-mediated inhibition of endo- by inserting into some particular locus recombination genous genes. The limitations of RNAi knockdown (KD) sequences such as loxp sites, which can mediate the and the fact that several key telomere regulators including deletion of intervening sequences upon the expression TRF2 and TIN2 are essential genes have complicated data of recombinases such as Cre [51–53]. The insertion of analysis and interpretation. Complete inactivation of these such exogenous sequences may alter gene regulation telomere regulatory genes in cells may cause cell death, and the entire process is often time consuming. To precluding further detailed biochemical and molecular generate conditional telosome subunit KO cells, we studies, especially experiments that require extended cul- modified a lentivirus-based inducible CRISPR/Cas9 turing and/or large numbers of cells. KO system [54], and constructed separate vectors for The advent of the CRISPR/Cas9 genome-editing tech- inducible Cas9 and constitutive single guide RNA nology has afforded investigators unprecedented opportu- (sgRNA) expression (Supplementary Figure S1B). nities to more efficiently and specifically target genes in Hela cells were transduced with lentiviruses encoding human cells and to explore the consequences of their inducible Cas9 and a clone in which Cas9 expression inactivation [39–47]. In this study, we took advantage of the could be reproducibly activated with doxycycline in a highly flexible and adaptable CRISPR/Cas9 system and dose-dependent manner was selected (Supplementary generated human inducible KO cell lines for each of the Figure S1C). telosome components. This panel of cells has allowed us to The double-strand breaks resulting from Cas9 clea- survey the functional significance of each telomeric protein vage trigger the non-homologous end joining DNA and probe the impact of individual subunit inhibition on repair pathway in the absence of a donor template telomere regulation as well as metabolic control. With this [55–57]. Non-homologous end joining-mediated DNA systematic analysis of the function of human telomere repair may generate small insertions and/or deletions proteins using inducible KO cell lines, we are able to better (indels) at the target site, and compromise gene func- delineate the differences between mouse and human telo- tion if cleavage occurs within protein coding sequences. mere biology. In addition, our panel of inducible KO cell Repair of a single Cas9 cleavage site has a 1/3 chance of lines should prove invaluable to investigators seeking to in-frame ligation of the coding sequences, which may further explore the consequences of telomere dysfunction not completely disrupt gene function. We reasoned that and to study how diverse cellular functions may be dis- simultaneous targeting with two sgRNAs should rupted upon telomere dysregulation. improve the odds of larger deletions and more com- plete inhibition of endogenous genes. To test this Results strategy, the inducible Cas9 cells were infected with two viruses encoding two separate TIN2-specific sgRNAs Using CRISPR/Cas9 to generate inducible KO human either singly or together, selected with appropriate cell lines antibiotics, and then cultured in doxycycline- Trf1, Trf2 and Tin2 have been reported to be containing media to induce Cas9 expression essential genes in mouse [48–50]. To determine the roles (Figure 1a). At different time points following Cell Discovery | www.nature.com/celldisc Hyeung Kim et al. 3 cell lines showed similar growth patterns in the absence of doxycycline, differences in growth rates became apparent between doxycycline-induced TIN2 KO cells after 4-day treatment. Growth of the single sgRNA TIN2 KO cells
Recommended publications
  • A Balanced Transcription Between Telomerase and the Telomeric DNA
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by HAL-ENS-LYON A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes. Emmanuelle Escoffier, Am´elieRezza, Aude Roborel de Climens, Aur´elie Belleville, Louis Gazzolo, Eric Gilson, Madeleine Duc Dodon To cite this version: Emmanuelle Escoffier, Am´elieRezza, Aude Roborel de Climens, Aur´elieBelleville, Louis Gaz- zolo, et al.. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.. Retrovirology, BioMed Central, 2005, 2, pp.77. <10.1186/1742-4690- 2-77>. <inserm-00089278> HAL Id: inserm-00089278 http://www.hal.inserm.fr/inserm-00089278 Submitted on 16 Aug 2006 HAL is a multi-disciplinary open access L'archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destin´eeau d´ep^otet `ala diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publi´esou non, lished or not. The documents may come from ´emanant des ´etablissements d'enseignement et de teaching and research institutions in France or recherche fran¸caisou ´etrangers,des laboratoires abroad, or from public or private research centers. publics ou priv´es. Retrovirology BioMed Central Research Open Access A balanced transcription between telomerase and the
    [Show full text]
  • Anti-TERF2 / Trf2 Antibody (ARG59099)
    Product datasheet [email protected] ARG59099 Package: 50 μg anti-TERF2 / Trf2 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes TERF2 / Trf2 Tested Reactivity Hu, Rat Tested Application IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name TERF2 / Trf2 Antigen Species Human Immunogen Recombinant protein corresponding to A81-K287 of Human TERF2 / Trf2. Conjugation Un-conjugated Alternate Names Telomeric DNA-binding protein; TRF2; TTAGGG repeat-binding factor 2; TRBF2; Telomeric repeat- binding factor 2 Application Instructions Application table Application Dilution IHC-P 0.5 - 1 µg/ml WB 0.1 - 0.5 µg/ml Application Note IHC-P: Antigen Retrieval: By heat mediation. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 60 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer 0.9% NaCl, 0.2% Na2HPO4, 0.05% Sodium azide and 5% BSA. Preservative 0.05% Sodium azide Stabilizer 5% BSA Concentration 0.5 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/3 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol TERF2 Gene Full Name telomeric repeat binding factor 2 Background This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex.
    [Show full text]
  • Anti-TERF2 / Trf2 Antibody (ARG59098)
    Product datasheet [email protected] ARG59098 Package: 100 μl anti-TERF2 / Trf2 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes TERF2 / Trf2 Tested Reactivity Hu, Ms Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name TERF2 / Trf2 Antigen Species Human Immunogen Recombinant protein of Human TERF2 / Trf2. Conjugation Un-conjugated Alternate Names Telomeric DNA-binding protein; TRF2; TTAGGG repeat-binding factor 2; TRBF2; Telomeric repeat- binding factor 2 Application Instructions Application table Application Dilution WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Jurkat Calculated Mw 60 kDa Observed Size 70kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Gene Symbol TERF2 Gene Full Name telomeric repeat binding factor 2 Background This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres.
    [Show full text]
  • The Shelterin Complex and Hematopoiesis
    The shelterin complex and hematopoiesis Morgan Jones, … , Catherine E. Keegan, Ivan Maillard J Clin Invest. 2016;126(5):1621-1629. https://doi.org/10.1172/JCI84547. Review Mammalian chromosomes terminate in stretches of repetitive telomeric DNA that act as buffers to avoid loss of essential genetic information during end-replication. A multiprotein complex known as shelterin prevents recognition of telomeric sequences as sites of DNA damage. Telomere erosion contributes to human diseases ranging from BM failure to premature aging syndromes and cancer. The role of shelterin telomere protection is less understood. Mutations in genes encoding the shelterin proteins TRF1-interacting nuclear factor 2 (TIN2) and adrenocortical dysplasia homolog (ACD) were identified in dyskeratosis congenita, a syndrome characterized by somatic stem cell dysfunction in multiple organs leading to BM failure and other pleiotropic manifestations. Here, we introduce the biochemical features and in vivo effects of individual shelterin proteins, discuss shelterin functions in hematopoiesis, and review emerging knowledge implicating the shelterin complex in hematological disorders. Find the latest version: https://jci.me/84547/pdf The Journal of Clinical Investigation REVIEW The shelterin complex and hematopoiesis Morgan Jones,1,2 Kamlesh Bisht,3 Sharon A. Savage,4 Jayakrishnan Nandakumar,3 Catherine E. Keegan,5,6 and Ivan Maillard7,8,9 1Graduate Program in Cellular and Molecular Biology, 2Medical Scientist Training Program, and 3Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA. 4Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. 5Department of Human Genetics, 6Department of Pediatrics, 7Life Sciences Institute, 8Division of Hematology-Oncology, Department of Internal Medicine, and 9Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA.
    [Show full text]
  • Characterization of Telomeric Repeat-Containing RNA (TERRA) Localization and Protein
    bioRxiv preprint doi: https://doi.org/10.1101/362632; this version posted July 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 Characterization of Telomeric Repeat-Containing RNA (TERRA) localization and protein 2 interactions in Primordial Germ Cells of the mouse 3 4 Running tittle: Characterization of TERRA in mouse PGCs 5 6 Summary sentence: TERRA transcription and interacting proteins during PGC development are 7 regulated in a dynamic fashion that is dependent on gestational age and sex 8 9 Keywords: TERRA, Primordial Germ Cells, Long non-coding RNA, Telomeres, SFPQ, NONO 10 11 Miguel A. Brieño-Enríquez2, Stefannie L. Moak, Anyul Abud-Flores1, and Paula E. Cohen2 12 Department of Biomedical Sciences and Center for Reproductive Genomics, Cornell University, Ithaca, 13 New York 14853, United States of America 14 1 Current Address: Facultad de Medicina de la, Universidad Autónoma de San Luis Potosí, San Luis 15 Potosí, México 16 2 Corresponding authors: [email protected] and [email protected] 17 18 19 20 21 Research reported in this publication was supported in part by the Eunice Kennedy Shriver National Institute of Child Health & Human 22 Development of the National Institutes of Health under Award Number K99HD090289 to M.A.B-E. A seed grant from the Cornell Center for 23 Reproductive Genomics to M.A.B-E, using funds obtained as part of the NICHD National Centers for Translational Research in Reproduction 24 and Infertility (NCTRI), award number P50HD076210 to P.E.C.
    [Show full text]
  • Chaperone Association with Telomere Binding Proteins
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2009 Chaperone Association with Telomere Binding Proteins Amy Depcrynski Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medical Genetics Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/1949 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Amy N. Depcrynski 2009 All Rights Reserved Chaperone Association with Telomere Binding Proteins A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. By Amy Nicole Depcrynski BS (Honors) Biology, Minor Chemistry Virginia Commonwealth University 1998-2003 Director: Shawn E. Holt, Associate Professor Department of Pathology, Pharmacology and Toxicology and Human and Molecular Genetics Virginia Commonwealth University Richmond, Virginia July 2009 ii Acknowledgements I would like to thank Dr. Shawn Holt for his guidance and patience over the past five years. He has helped me to become a better student, teacher and scientist. I would like to thank current Holt/Elmore lab members, especially Malissa Diehl for all of her help, sympathy, and most of all humor. I would also like to thank Dr. Lynne Elmore and past lab members Kennon Daniels and Sarah Compton for their advice on numerous experiments, as well as my committee for their helpful suggestions. I would like to thank my family and friends for motivating me with their continued encouragement.
    [Show full text]
  • Multifunctionality of the Telomere-Capping Shelterin Complex Explained by Variations in Its Protein Composition
    cells Review Multifunctionality of the Telomere-Capping Shelterin Complex Explained by Variations in Its Protein Composition Claire Ghilain 1, Eric Gilson 1,2,3,* and Marie-Josèphe Giraud-Panis 1,* 1 Université Côte d’Azur, CNRS, INSERM, IRCAN, 06000 Nice, France; [email protected] 2 International Research Laboratory for Cancer, Aging and Hematology, Shanghai Ruijin Hospital, Shanghai Jiaotong University and Côte-d’Azur University, Shanghai 200025, China 3 Department of Genetics, CHU Nice, 06000 Nice, France * Correspondence: [email protected] (E.G.); [email protected] (M.-J.G.-P.) Abstract: Protecting telomere from the DNA damage response is essential to avoid the entry into cellular senescence and organismal aging. The progressive telomere DNA shortening in dividing somatic cells, programmed during development, leads to critically short telomeres that trigger replicative senescence and thereby contribute to aging. In several organisms, including mammals, telomeres are protected by a protein complex named Shelterin that counteract at various levels the DNA damage response at chromosome ends through the specific function of each of its subunits. The changes in Shelterin structure and function during development and aging is thus an intense area of research. Here, we review our knowledge on the existence of several Shelterin subcomplexes and the functional independence between them. This leads us to discuss the possibility that the multifunctionality of the Shelterin complex is determined by the formation of different subcomplexes Citation: Ghilain, C.; Gilson, E.; whose composition may change during aging. Giraud-Panis, M.-J. Multifunctionality of the Keywords: telomere; aging; Shelterin; senescence; DNA damage response Telomere-Capping Shelterin Complex Explained by Variations in Its Protein Composition.
    [Show full text]
  • Shortened Leukocyte Telomere Length in Type 2 Diabetes Mellitus: Genetic
    Zhou et al. Clin Trans Med (2016) 5:8 DOI 10.1186/s40169-016-0089-2 REVIEW Open Access Shortened leukocyte telomere length in type 2 diabetes mellitus: genetic polymorphisms in mitochondrial uncoupling proteins and telomeric pathways Yuling Zhou1, Zhixin Ning1, Yvonne Lee1, Brett D. Hambly2 and Craig S. McLachlan1* Abstract Current debate in type 2 diabetes (T2DM) has focused on shortened leukocyte telomere length (LTL) as the result of a number of possible causes, including polymorphisms in mitochondrial uncoupling proteins (UCPs) leading to oxida- tive stress, telomere regulatory pathway gene polymorphisms, or as a direct result of associated cardiovascular com- plications inducing tissue organ inflammation and oxidative stress. There is evidence that a heritable shorter telomere trait is a risk factor for development of T2DM. This review discusses the contribution and balance of genetic regulation of UCPs and telomere pathways in the context of T2DM. We discuss genotypes that are well known to influence the shortening of LTL, in particular OBFC1 and telomerase genotypes such as TERC. Interestingly, the interaction between short telomeres and T2DM risk appears to involve mitochondrial dysfunction as an intermediate process. A hypothesis is presented that genetic heterogeneity within UCPs may directly affect oxidative stress that feeds back to influence the fine balance of telomere regulation, cell cycle regulation and diabetes risk and/or metabolic disease progression. Keywords: Telomere length, Type 2 diabetes, Genetics, Uncoupling protein polymorphisms, Telomere-associated pathway genes Telomere length varies from 4–20 kb in humans and tel- Leukocyte telomere length (LTL) is associated omere shortening is thought to be key mechanistic event with metabolic disease and cardiovascular risk in cellular aging [1–3].
    [Show full text]
  • MINI-REVIEW Shelterin Proteins and Cancer
    DOI:http://dx.doi.org/10.7314/APJCP.2015.16.8.3085 Shelterin Proteins and Cancer MINI-REVIEW Shelterin Proteins and Cancer Trupti NV Patel*, Richa Vasan, Divanshu Gupta, Jay Patel, Manjari Trivedi Abstract The telomeric end structures of the DNA are known to contain tandem repeats of TTAGGG sequence bound with specialised protein complex called the “shelterin complex”. It comprises six proteins, namely TRF1, TRF2, TIN2, POT1, TPP1 and RAP1. All of these assemble together to form a complex with double strand and single strand DNA repeats at the telomere. Such an association contributes to telomere stability and its protection from undesirable DNA damage control-specific responses. However, any alteration in the structure and function of any of these proteins may lead to undesirable DNA damage responses and thus cellular senescence and death. In our review, we throw light on how mutations in the proteins belonging to the shelterin complex may lead to various malfunctions and ultimately have a role in tumorigenesis and cancer progression. Keywords: Shelterin proteins - telomeres - telomerase - tumorigenesis Asian Pac J Cancer Prev, 16 (8), 3085-3090 Introduction et al., 1997; Huaweiet al., 2008). Furthermore, research revealed that TRF1 forms homodimer prior to its Shelterin is a protein complex at the end of the association with the telomeric double strand DNA (Lingjun chromosomes, shaped by six telomere-specific proteins et al., 2011).The stability and telomere binding affinity is and functioning as a safeguard for the chromosome ends negatively influenced by the interactions of TRF1 with (Huawei et al., 2008). The name “shelterin” is derived Nucleostemin(NS) and positively influenced by that of by analogy to other chromosomal protein complexes GNL3L (guanine nucleotide binding protein-like-3-like).
    [Show full text]
  • Roles for Recq Helicases in Telomere Preservation
    Roles for RecQ Helicases in Telomere Preservation Patricia L. Opresko University of Pittsburgh Department of Environmental and Occupational Health Bridgeside Point 100 Technology Drive, Suite 350 Pittsburgh, PA 15219-3130 [email protected] Werner Syndrome Symptoms Average Age of Onset (yrs) Greying of hair 20 Wrinkling of the skin 25.3 Loss of hair 25.8 Cataracts 30 Skin Ulcers 30 14 Years Old Diabetes (type II) 34.2 Death 47 Osteoporosis Atherosclerosis Cancer 48 Years Old RecQ Family “Care Takers” of the Genome RecQ, E. coli Sgs1, S. cer. Rqh1, S. pombe FFA-1, X. laevis RecQ5β, D. melanogaster RecQL, H. sapiens BLM, H. sapiens WRN, H. sapiens RecQ4, H. sapiens RecQ5β, H. sapiens Exonuclease AcidicHelicase RecQ HRDC NLS 3’ to 5’ 3’ to 5’ conserved Cellular defects in WS cell lines • Genomic Instability • DNA Repair – Chromosomal – Hypersensitivity to rearrangements, 4-NQO translocations, dicentrics DNA crosslinking agents – Large deletions topoisomerase inhibitors methyl methanesulfonate • Replication – Reduced replicative lifespan • Telomere instability – Extended S-phase • Mitotic Homologous DNA Recombination – Defect in resolving intermediates Telomere-Associated Replicative Senescence Germ cells: Germ sufficient telomerase activity - no shortening A dul Adult stem cells: t S s variable levels of telomerase activity o te m m a + exogenous - slow shortening t ic telomerase Somatic cells: most have no telomerase activity - exhibit faster rates of shortening telomere- senescencesenescence se dependent era m Cancer cells: Telo ALT 90% show
    [Show full text]
  • The Cooperative Assembly of Shelterin Bridge Provides a Kinetic Gateway That Controls Telomere Length Homeostasis
    ms file bioRxiv preprint doi: https://doi.org/10.1101/2020.07.31.231530; this version posted August 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The cooperative assembly of shelterin bridge provides a kinetic gateway that controls telomere length homeostasis Jinqiang Liu,1 Xichan Hu,1 Kehan Bao,2 Jin-Kwang Kim,1 Songtao Jia,2 and Feng Qiao1,* 1Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697-1700 2Department of Biological Sciences, Columbia University, New York City, NY 92697-4560 *To whom correspondence should be addressed. 240D Medical Science I Department of Biological Chemistry School of Medicine University of California, Irvine Irvine, CA 92697-1700 Email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.07.31.231530; this version posted August 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Shelterin is a six-proteins complex that coats chromosome ends to ensure their proper protection and maintenance. Similar to the human shelterin, fission yeast shelterin is composed of telomeric double- and single-stranded DNA-binding proteins, Taz1 and Pot1, respectively, bridged by Rap1, Poz1, and Tpz1. The assembly of the proteinaceous Tpz1-Poz1-Rap1 complex occurs cooperatively and disruption of this shelterin bridge leads to unregulated telomere elongation. However, how this biophysical property of bridge assembly is integrated into shelterin function is not known.
    [Show full text]
  • What I Got Wrong About Shelterin
    ASBMB AWARD ARTICLE cro What I got wrong about shelterin Published, Papers in Press, May 23, 2018, DOI 10.1074/jbc.AW118.003234 X Titia de Lange1 From the Laboratory for Cell Biology and Genetics, Rockefeller University, New York, New York 10065 Edited by Joel Gottesfeld The ASBMB 2018 Bert and Natalie Vallee award in Biomedi- astating news to me at a New Year’s Eve party: the activity she cal Sciences honors our work on shelterin, a protein complex was looking at had higher affinity for RNA than DNA. A few that helps cells distinguish the chromosome ends from sites of years later, first Howard Cooke and then Tom Cech published DNA damage. Shelterin protects telomeres from all aspects of on the activity that Lily had detected, which turned out to be the DNA damage response, including ATM and ATR serine/ due to hnRNPA1 and other similar RNA-binding proteins (5, threonine kinase signaling and several forms of double-strand 6). So, our New Year’s resolution for 1989 was to look for pro- break repair. Today, this six-subunit protein complex could eas- teins bound to double-stranded (ds) TTAGGG repeats instead. Downloaded from ily be identified in one single proteomics step. But, it took us This search yielded a much less abundant binding activity that more than 15 years to piece together the entire shelterin com- was specific for DNA, not RNA. We called it TRF (telomeric plex, one protein at a time. Although we did a lot of things right, repeat binding factor). here I tell the story of shelterin’s discovery with an emphasis on In June 1989, the Rockefeller University offered me a posi- the things that I got wrong along the way.
    [Show full text]